Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02298881 · ClinicalTrials.gov registry record

Ocular Surface Microbiome

A clinical trial, sponsored by University of Washington.

Completed
Registry status
80
Enrollment target

NCT02298881: Completed study, sponsored by University of Washington.

NCT02298881 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02298881 has completed, sponsored by University of Washington.

COMPLETED
Registry status
80 participants
Enrollment target

Study Summary

The purpose of this study is to collect samples from the surface of eyelids to try to grow and identify bacteria or fungus that might be present, and to try to understand why people have dry eye symptoms.

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-07
Est. Completion 2021-05-01
University of Washington

1,048 total trials

What the finished NCT02298881 record still lists

NCT02298881 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02298881 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02298881 about?

NCT02298881 is a clinical study titled "Ocular Surface Microbiome". The purpose of this study is to collect samples from the surface of eyelids to try to grow and identify bacteria or fungus that might be present, and to try to understand why people have dry eye symptoms.

What is the current status of trial NCT02298881?

This trial is currently completed. The enrollment target is 80 participants. The study started on 2013-07. Estimated completion is 2021-05-01.

Who is sponsoring clinical trial NCT02298881?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02298881, the US trial registry maintained by the National Library of Medicine. NCT02298881 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.